ヘルスケア/医療シミュレーション市場 : 2027 年までの世界予測

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2022年10月

ヘルスケア/医療シミュレーション市場 : 製品とサービス (解剖モデル、患者シミュレータ (高忠実度、低忠実度)、タスクトレーナー、手術シミュレータ、ソフトウェア、サービス)、エンド ユーザー (学術機関、病院) – 2027 年までの世界予測
Healthcare/Medical Simulation Market by Product and Service (Anatomical Models, Patient Simulators (High Fidelity, Low Fidelity), Task Trainer, Surgical Simulators, Software, Services), End User (Academic Institutes, Hospital) – Global Forecast to 2027

ページ数 303
図表数 258
種別 英文調査報告書
価格

レポート目次    お問合せ・ご注文    価格・納期について

無料サンプル

The global medical simulation market is projected to reach USD 4.2 billion by 2027 from USD 1.9 billion in 2022, at a CAGR of 16.1% during the forecast period. Growth in this market is driven by the rising focus on patient safety, growing preference for virtual interaction. However, lack of skilled healthcare professionals and high cost of simulators are expected to restrain the growth of this market to a certain extent.

ヘルスケア/医療シミュレーション市場 : 製品とサービス (解剖モデル、患者シミュレータ (高忠実度、低忠実度)、タスク トレーナー、手術シミュレータ、ソフトウェア、サービス)、エンド ユーザー (学術機関、病院) - 2027 年までの世界予測

“The web-based simulation segment registered the highest growth in the medical simulation market, by product & service”
Based on the type, the web-based simulation segment registered the highest growth in the medical simulation market during the forecast period. Factors responsible for the growth of this segment is the wide availability of internet services, growing government initiatives for adopting HCIT solutions.

“Academic institutes was the largest segment by the end user of medical simulation market in 2021”
Academic institutes segment is projected to grow at the highest growth rate in the medical simulation market in 2021.Increasing utilization of simulation models in medical surgeries, increasing focus on minimizing errors, and cost-effectiveness of procedural training for medical physicians is expected to drive the demand for medical simulation services in the coming years.

“APAC to witness the highest growth rate during the forecast period.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by factors such as the rising focus on medical research, growing medical tourism, increasing healthcare expenditure, and the rising purchasing power of consumers.

The break-down of primary participants is as mentioned below:
• By Company Type – Tier 1:55%, Tier 2: 30%, and Tier 3: 15%
• By Designation – C-level: 50%, Director-level: 35%,and Others: 15%
• By Region – North America: 48%,Europe: 32%,AsiaPacific: 15%,Rest of the World: 5%

Key players in the Medical simulation Market
The key players operating in the medical simulation market includeCAE (Canada), Laerdal Medical (Norway), Simulab Corporation (US), Simulaids (US), Limbs & Things (UK), Kyoto Kagaku (Japan), Mentice AB (Sweden), Gaumard Scientific Co. (US), Operative Experience Inc. (US), Cardionics Inc. (US) (a subsidiary of 3B Scientific), VirtaMed AG (Switzerland), SYNBONE AG (Switzerland), IngMar Medical (US), Medical-X (Netherlands), KaVo Dental GmbH (Germany), Altay Scientific (Italy), Simendo B.V. (Netherlands) VRMagic Holding AG (Germany), Symgery (Canada), HRV Simulation (France), Synaptive Medical (Canada), Inovus Medical (UK), TruCorp Ltd. (Ireland), and Surgical Science Sweden AG (Sweden).

ヘルスケア/医療シミュレーション市場 : 製品とサービス (解剖モデル、患者シミュレータ (高忠実度、低忠実度)、タスク トレーナー、手術シミュレータ、ソフトウェア、サービス)、エンド ユーザー (学術機関、病院) - 2027 年までの世界予測
Research Coverage:
The report analyses the medical simulation market and aims to estimate the market size and future growth potential of various market segments, based on components, delivery mode, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market.


目次

1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION AND SCOPE 32
1.2.1 INCLUSIONS AND EXCLUSIONS 32
1.2.2 MARKET SEGMENTATION 33
FIGURE 1 MEDICAL SIMULATION MARKET SEGMENTATION 33
1.2.3 YEARS CONSIDERED 34
1.3 CURRENCY 34
1.4 STAKEHOLDERS 35
1.5 SUMMARY OF CHANGES 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
2.2 RESEARCH METHODOLOGY DESIGN 36
FIGURE 2 MEDICAL SIMULATION MARKET: RESEARCH DESIGN 36
2.2.1 SECONDARY RESEARCH 37
2.2.1.1 Key data from secondary sources 38
2.2.2 PRIMARY DATA 38
FIGURE 3 PRIMARY SOURCES 38
2.2.2.1 Key data from primary sources 39
2.2.2.2 Insights from primary experts 40
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 40
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION 41
2.3 MARKET SIZE ESTIMATION: MEDICAL SIMULATION MARKET 41
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 42
FIGURE 7 REVENUE ANALYSIS OF TOP 3 PUBLIC COMPANIES: MEDICAL SIMULATION MARKET (2021) 42
FIGURE 8 BOTTOM-UP APPROACH: SEGMENTAL EXTRAPOLATION 43
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 45
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 46
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 47
FIGURE 11 DATA TRIANGULATION METHODOLOGY 47
2.5 MARKET SHARE ESTIMATION 48
2.6 ASSUMPTIONS 48
2.7 LIMITATIONS 48
2.7.1 METHODOLOGY-RELATED LIMITATIONS 48
2.7.2 SCOPE-RELATED LIMITATIONS 49
2.8 RISK ASSESSMENT 49
TABLE 1 RISK ASSESSMENT: MEDICAL SIMULATION MARKET 49
3 EXECUTIVE SUMMARY 50
FIGURE 12 MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION) 50
FIGURE 13 INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 51
FIGURE 14 MEDICAL SIMULATION MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 51
FIGURE 15 MEDICAL SIMULATION MARKET: REGIONAL SNAPSHOT 52
4 PREMIUM INSIGHTS 53
4.1 MEDICAL SIMULATION MARKET OVERVIEW 53
FIGURE 16 ADVANCEMENTS IN MEDICAL TECHNOLOGIES TO DRIVE MARKET GROWTH 53
4.2 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE AND COUNTRY (2021) 54
FIGURE 17 MEDICAL SIMULATION ANATOMICAL MODELS SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2021 54
4.3 MEDICAL SIMULATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 55
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 55
4.4 REGIONAL MIX: MEDICAL SIMULATION MARKET 56
FIGURE 19 NORTH AMERICA TO DOMINATE MEDICAL SIMULATION MARKET DURING FORECAST PERIOD 56
4.5 MEDICAL SIMULATION MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 57
FIGURE 20 DEVELOPING COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 57
5 MARKET OVERVIEW 58
5.1 INTRODUCTION 58
5.2 MARKET DYNAMICS 58
FIGURE 21 MEDICAL SIMULATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 58
TABLE 2 MARKET DYNAMICS: IMPACT ANALYSIS 59
5.2.1 DRIVERS 59
5.2.1.1 Limited access to patients during medical training 59
5.2.1.2 Rising technological advancements in medical education 60
5.2.1.3 Growing demand for minimally invasive treatments 60
FIGURE 22 TOTAL CASE NUMBERS REPORTED BY GENERAL SURGERY RESIDENTS FOR OPEN SURGERIES: 16-YEAR ANALYSIS (2003–2019) 61
FIGURE 23 TOTAL CASE NUMBERS REPORTED BY GENERAL SURGERY RESIDENTS FOR LAPAROSCOPIC SURGERIES: 16-YEAR ANALYSIS (2003–2019) 61
5.2.1.4 Increasing focus on patient safety 61
FIGURE 24 GLOBAL MEDICATION ERROR REPORTING MARKET SHARE, 2018 VS. 2026 62
5.2.1.5 Growing preference for virtual interaction 62
5.2.2 RESTRAINTS 63
5.2.2.1 Limited availability of funds 63
5.2.2.2 Poorly designed medical simulators 63
5.2.3 OPPORTUNITIES 64
5.2.3.1 Shortage of healthcare personnel 64
5.2.3.2 Growing awareness about simulation training in emerging economies 64
5.2.4 CHALLENGES 65
5.2.4.1 High cost of simulators 65
5.2.4.2 Operational challenges 65
6 INDUSTRY INSIGHTS 66
6.1 INTRODUCTION 66
6.2 INDUSTRY TRENDS 66
6.2.1 USE OF VIRTUAL REALITY (VR) AND AUGMENTED REALITY (AR) IN MEDICAL SIMULATION 66
6.2.2 HIGH-FIDELITY TECHNOLOGICAL ADVANCEMENTS 67
6.2.3 MULTIMODAL APPROACH IN DEVELOPMENT OF SIMULATORS 67
6.2.4 UTILIZATION OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING SOFTWARE IN SURGICAL PROCEDURES 67
6.2.5 GROWING USE OF HCIT/EMR 68
6.3 REGULATORY ANALYSIS 68
6.3.1 MEDICAL SIMULATION PRODUCTS 68
6.3.1.1 North America 68
6.3.1.1.1 US 68
TABLE 3 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 69
6.3.1.1.1 Canada 69
6.3.1.2 Europe 69
6.3.1.3 Asia Pacific 69
6.3.1.3.1 Japan 69
TABLE 4 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY IN JAPAN 70
6.3.1.3.2 China 70
TABLE 5 NMPA MEDICAL DEVICE CLASSIFICATION 70
6.3.1.3.3 India 71
6.3.2 INTEROPERABILITY STANDARDS 71
TABLE 6 KEY STANDARDS FOR INTEROPERABILITY IN DIGITAL HEALTH SPECTRUM 71
TABLE 7 QUALITATIVE ANALYSIS OF WIDELY USED DATA TRANSMISSION STANDARDS IN DIGITAL HEALTH SPECTRUM 74
6.3.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 8 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74

6.4 PORTER’S FIVE FORCES ANALYSIS 75
TABLE 9 PORTER’S FIVE FORCES ANALYSIS 75
6.4.1 THREAT OF NEW ENTRANTS 75
6.4.2 THREAT OF SUBSTITUTES 76
6.4.3 BARGAINING POWER OF SUPPLIERS 76
6.4.4 BARGAINING POWER OF BUYERS 76
6.4.5 INTENSITY OF COMPETITIVE RIVALRY 76
6.5 PRICING ANALYSIS 77
TABLE 10 PRICE RANGE FOR MEDICAL SIMULATION SOLUTIONS 77
6.6 TECHNOLOGY ANALYSIS 77
6.7 ECOSYSTEM ANALYSIS 78
6.7.1 MEDICAL SIMULATION MARKET: ECOSYSTEM ANALYSIS 79
6.8 PATENT ANALYSIS 79
6.8.1 PATENT PUBLICATION TRENDS FOR MEDICAL SIMULATION 80
FIGURE 25 PATENT PUBLICATION TRENDS (JANUARY 2012–AUGUST 2022) 80
6.8.2 JURISDICTION AND TOP APPLICANT ANALYSIS 80
FIGURE 26 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR MEDICAL SIMULATION PATENTS (JANUARY 2012 TO AUGUST 2022) 81
FIGURE 27 TOP APPLICANT COUNTRIES/REGIONS FOR MEDICAL SIMULATION PATENTS (JANUARY 2012 TO AUGUST 2022) 81
6.9 VALUE CHAIN ANALYSIS 82
FIGURE 28 MEDICAL SIMULATION MARKET: VALUE CHAIN ANALYSIS 82
6.10 CASE STUDY 83
6.11 KEY CONFERENCES AND EVENTS 84
TABLE 11 HEALTHCARE/MEDICAL SIMULATION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 84
6.12 KEY STAKEHOLDERS AND BUYING CRITERIA 85
6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 85
FIGURE 29 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 END USERS 85
TABLE 12 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 END USERS 85
6.12.2 BUYING CRITERIA 86
FIGURE 30 KEY BUYING CRITERIA FOR TOP 3 END USERS 86
TABLE 13 KEY BUYING CRITERIA FOR TOP 3 END USERS 86
7 MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE 87
7.1 INTRODUCTION 88
TABLE 14 MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 88
7.2 MEDICAL SIMULATION ANATOMICAL MODELS 88
TABLE 15 MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 89
TABLE 16 MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.1 PATIENT SIMULATORS 90
TABLE 17 PATIENT SIMULATORS OFFERED BY KEY MARKET PLAYERS 90
TABLE 18 PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 92
TABLE 19 PATIENT SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.1.1 High-fidelity simulators 93
7.2.1.1.1 Growing adoption of high-fidelity simulators in educational training to drive growth 93
TABLE 20 HIGH-FIDELITY SIMULATORS OFFERED BY KEY MARKET PLAYERS 93
TABLE 21 HIGH-FIDELITY PATIENT SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.1.2 Medium-fidelity simulators 94
7.2.1.2.1 Cost benefits of medium-fidelity simulation to drive demand 94
TABLE 22 MEDIUM-FIDELITY SIMULATORS OFFERED BY KEY MARKET PLAYERS 95
TABLE 23 MEDIUM-FIDELITY PATIENT SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.2.1.3 Low-fidelity simulators 96
7.2.1.3.1 Budgetary constraints and ease of use to drive demand 96
TABLE 24 LOW-FIDELITY SIMULATORS OFFERED BY KEY MARKET PLAYERS 96
TABLE 25 LOW-FIDELITY PATIENT SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.2.2 TASK TRAINERS 97
7.2.2.1 Inability to imitate emotional attributes of patients to restrain growth 97
TABLE 26 TASK TRAINERS OFFERED BY KEY MARKET PLAYERS 98
TABLE 27 TASK TRAINERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99
7.2.3 INTERVENTIONAL/SURGICAL SIMULATORS 99
TABLE 28 INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 100
TABLE 29 INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 100
7.2.3.1 Laparoscopic surgical simulators 101
7.2.3.1.1 Increasing preference for minimally invasive surgeries to drive growth 101
TABLE 30 LAPAROSCOPIC SURGICAL SIMULATORS OFFERED BY KEY MARKET PLAYERS 101
TABLE 31 LAPAROSCOPIC SURGICAL SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 102
7.2.3.2 Gynecology simulators 102
7.2.3.2.1 Increasing incidence of fibroids and polyps in women to drive demand for gynecology simulators 102
TABLE 32 GYNECOLOGY SIMULATORS OFFERED BY KEY MARKET PLAYERS 103
TABLE 33 GYNECOLOGY SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 103
7.2.3.3 Cardiovascular simulators 104
7.2.3.3.1 Increasing prevalence of obesity and diabetes to boost demand 104
TABLE 34 CARDIOVASCULAR SIMULATORS OFFERED BY KEY MARKET PLAYERS 104
TABLE 35 CARDIOVASCULAR SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 105
7.2.3.4 Orthopedic surgical simulators 105
7.2.3.4.1 Growing number of orthopedic surgeries to drive demand 105
TABLE 36 ORTHOPEDIC SIMULATORS OFFERED BY KEY MARKET PLAYERS 106
TABLE 37 ORTHOPEDIC SURGICAL SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 106
7.2.3.5 Spine surgical simulators 107
7.2.3.5.1 Increasing incidence of spinal injuries to boost growth 107
TABLE 38 SPINE SURGICAL SIMULATORS OFFERED BY KEY MARKET PLAYERS 107
TABLE 39 SPINE SURGICAL SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 108
7.2.3.6 Other surgical simulators 108
TABLE 40 OTHER SURGICAL SIMULATORS OFFERED BY KEY MARKET PLAYERS 109
TABLE 41 OTHER SURGICAL SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 109
7.2.4 ENDOVASCULAR SIMULATORS 110
7.2.4.1 Endovascular simulators help in reducing mortality rates 110
TABLE 42 ENDOVASCULAR SIMULATORS OFFERED BY KEY MARKET PLAYERS 110
TABLE 43 ENDOVASCULAR SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 111
7.2.5 ULTRASOUND SIMULATORS 111
7.2.5.1 Inferior quality images resulting from low dynamics and spatial resolution to restrain growth 111
TABLE 44 ULTRASOUND SIMULATORS OFFERED BY KEY MARKET PLAYERS 112
TABLE 45 ULTRASOUND SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 113
7.2.6 DENTAL SIMULATORS 113
7.2.6.1 Expanding dental tourism industry to drive growth 113
TABLE 46 DENTAL SIMULATORS OFFERED BY KEY MARKET PLAYERS 114
TABLE 47 DENTAL SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 114
7.2.7 EYE SIMULATORS 115
7.2.7.1 Increasing incidence of eye disorders to drive growth 115
TABLE 48 EYE SIMULATORS OFFERED BY KEY MARKET PLAYERS 115
TABLE 49 EYE SIMULATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 116
7.3 WEB-BASED SIMULATION 116
7.3.1 RISING TECHNOLOGICAL ADVANCEMENTS DRIVING ADOPTION OF WEB-BASED SIMULATION 116
TABLE 50 WEB-BASED SIMULATORS OFFERED BY KEY MARKET PLAYERS 117
TABLE 51 WEB-BASED SIMULATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 117
7.4 MEDICAL SIMULATION SOFTWARE 118
7.4.1 KEY ADVANTAGES OFFERED BY MEDICAL SIMULATION SOFTWARE TO DRIVE ADOPTION 118
TABLE 52 MEDICAL SIMULATION SOFTWARE OFFERED BY KEY MARKET PLAYERS 118
TABLE 53 MEDICAL SIMULATION SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 119
7.5 SIMULATION TRAINING SERVICES 119
TABLE 54 MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 55 MEDICAL SIMULATION TRAINING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 120
7.5.1 VENDOR-BASED TRAINING 121
7.5.1.1 High focus on patient safety to drive demand 121
TABLE 56 VENDOR-BASED TRAINING SERVICES OFFERED BY KEY MARKET PLAYERS 121
TABLE 57 VENDOR-BASED TRAINING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 122
7.5.2 EDUCATIONAL SOCIETIES 122
7.5.2.1 Growing need for proper training and authenticity of knowledge to drive growth 122
TABLE 58 EDUCATIONAL SOCIETIES SIMULATORS OFFERED BY KEY MARKET PLAYERS 123
TABLE 59 EDUCATIONAL SOCIETIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
7.5.3 CUSTOM CONSULTING SERVICES 124
7.5.3.1 Growing need to limit errors associated with traditional medical training systems to drive growth 124
TABLE 60 CUSTOM CONSULTING SERVICES OFFERED BY KEY MARKET PLAYERS 124
TABLE 61 CUSTOM CONSULTING SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 125
8 MEDICAL SIMULATION MARKET, BY END USER 126
8.1 INTRODUCTION 127
TABLE 62 MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 127
8.2 ACADEMIC INSTITUTES 127
8.2.1 GROWING NEED FOR SKILLED MEDICAL PROFESSIONALS TO DRIVE DEMAND 127
TABLE 63 MEDICAL SIMULATION MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 128
8.3 HOSPITALS 129
8.3.1 RISING FOCUS ON MINIMIZING MEDICAL ERRORS TO DRIVE DEMAND 129
TABLE 64 MEDICAL SIMULATION MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 130
8.4 MILITARY ORGANIZATIONS 130
8.4.1 FOCUS ON EXPLORING NEW METHODS OF MEDICAL CARE DURING WARFARE TO DRIVE DEMAND 130
TABLE 65 MEDICAL SIMULATION MARKET FOR MILITARY ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 131
8.5 OTHER END USERS 131
TABLE 66 MEDICAL SIMULATION MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 132

9 MEDICAL SIMULATION MARKET, BY REGION 133
9.1 INTRODUCTION 134
TABLE 67 MEDICAL SIMULATION MARKET, BY REGION, 2020–2027 (USD MILLION) 134
9.2 NORTH AMERICA 134
FIGURE 31 NORTH AMERICA: MEDICAL SIMULATION MARKET SNAPSHOT (2021) 135
TABLE 68 NORTH AMERICA: MEDICAL SIMULATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 136
TABLE 69 NORTH AMERICA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 136
TABLE 70 NORTH AMERICA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 71 NORTH AMERICA: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 72 NORTH AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 73 NORTH AMERICA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 137
TABLE 74 NORTH AMERICA: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 138
9.2.1 US 138
9.2.1.1 Increasing demand for virtual tutors and high healthcare spending to boost growth 138
TABLE 75 US: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 139
TABLE 76 US: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 77 US: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 78 US: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 79 US: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 80 US: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 141
9.2.2 CANADA 141
9.2.2.1 Increasing funding and surgical capabilities to drive growth 141
TABLE 81 CANADA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 142
TABLE 82 CANADA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 83 CANADA: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 84 CANADA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 85 CANADA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 86 CANADA: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 144
9.3 EUROPE 144
TABLE 87 EUROPE: MEDICAL SIMULATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 145
TABLE 88 EUROPE: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 145
TABLE 89 EUROPE: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 90 EUROPE: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 91 EUROPE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 92 EUROPE: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 93 EUROPE: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 148
9.3.1 UK 148
9.3.1.1 Rising number of healthcare simulation centers and hospitals to drive growth 148
TABLE 94 UK: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 149
TABLE 95 UK: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 96 UK: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 97 UK: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 98 UK: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 99 UK: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 151
9.3.2 FRANCE 151
9.3.2.1 Growing focus on use of innovative methods in medical training to drive growth 151
TABLE 100 FRANCE: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 152
TABLE 101 FRANCE: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 102 FRANCE: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 103 FRANCE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 104 FRANCE: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 105 FRANCE: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 154
9.3.3 GERMANY 154
9.3.3.1 High healthcare spending to drive growth 154
TABLE 106 GERMANY: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 155
TABLE 107 GERMANY: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 108 GERMANY: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 109 GERMANY: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 110 GERMANY: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 111 GERMANY: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 157
9.3.4 ITALY 157
9.3.4.1 Shortage of trained healthcare personnel to drive growth 157
TABLE 112 ITALY: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 158
TABLE 113 ITALY: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 114 ITALY: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 115 ITALY: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 116 ITALY: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 117 ITALY: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 160
9.3.5 SPAIN 160
9.3.5.1 Increasing number of surgical procedures to boost growth 160
TABLE 118 SPAIN: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 161
TABLE 119 SPAIN: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 120 SPAIN: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 121 SPAIN: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 122 SPAIN: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 123 SPAIN: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 163
9.3.6 REST OF EUROPE 163
TABLE 124 ROE: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 164
TABLE 125 ROE: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 164
TABLE 126 ROE: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 127 ROE: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 128 ROE: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 129 ROE: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 166
9.4 ASIA PACIFIC 166
FIGURE 32 ASIA PACIFIC: MEDICAL SIMULATION MARKET SNAPSHOT (2021) 167
TABLE 130 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 168
TABLE 131 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 168
TABLE 132 ASIA PACIFIC: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 133 ASIA PACIFIC: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 134 ASIA PACIFIC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 170
TABLE 135 ASIA PACIFIC: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 170
TABLE 136 ASIA PACIFIC: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 171
9.4.1 JAPAN 171
9.4.1.1 Increasing demand for virtual tutors and technologically advanced simulators to drive growth 171
TABLE 137 JAPAN: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 172
TABLE 138 JAPAN: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 139 JAPAN: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 140 JAPAN: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 141 JAPAN: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 142 JAPAN: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 174
9.4.2 CHINA 174
9.4.2.1 Increasing demand for trained medical professionals to drive growth 174
TABLE 143 CHINA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 175
TABLE 144 CHINA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 145 CHINA: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 146 CHINA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 147 CHINA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 148 CHINA: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 177
9.4.3 INDIA 177
9.4.3.1 Growing awareness regarding patient safety due to healthcare negligence to drive growth 177
TABLE 149 INDIA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 178
TABLE 150 INDIA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 151 INDIA: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 152 INDIA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 153 INDIA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 154 INDIA: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 180
9.4.4 REST OF ASIA PACIFIC 180
TABLE 155 ROAPAC: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 181
TABLE 156 ROAPAC: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 157 ROAPAC: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 158 ROAPAC: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 159 ROAPAC: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 160 ROAPAC: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 183
9.5 LATIN AMERICA 183
TABLE 161 LATIN AMERICA: MEDICAL SIMULATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 183
TABLE 162 LATIN AMERICA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 184
TABLE 163 LATIN AMERICA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 184
TABLE 164 LATIN AMERICA: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 165 LATIN AMERICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 166 LATIN AMERICA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 167 LATIN AMERICA: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 186
9.5.1 BRAZIL 186
9.5.1.1 High incidence of chronic diseases to drive growth 186
TABLE 168 BRAZIL: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 187
TABLE 169 BRAZIL: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 187
TABLE 170 BRAZIL: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 171 BRAZIL: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 172 BRAZIL: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 173 BRAZIL: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 189
9.5.2 MEXICO 189
9.5.2.1 Disruptive technologies and public-private partnerships to boost growth 189
TABLE 174 MEXICO: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 190
TABLE 175 MEXICO: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 190
TABLE 176 MEXICO: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 177 MEXICO: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 178 MEXICO: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 179 MEXICO: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 192
9.5.3 REST OF LATIN AMERICA 192
TABLE 180 ROLA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 192
TABLE 181 ROLA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 182 ROLA: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 183 ROLA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 194
TABLE 184 ROLA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 194
TABLE 185 ROLA: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 195
9.6 MIDDLE EAST & AFRICA 195
9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO DRIVE GROWTH 195
TABLE 186 MIDDLE EAST & AFRICA: MEDICAL SIMULATION MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 196
TABLE 187 MIDDLE EAST & AFRICA: MEDICAL SIMULATION ANATOMICAL MODELS MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 188 MIDDLE EAST & AFRICA: PATIENT SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 197
TABLE 189 MIDDLE EAST & AFRICA: INTERVENTIONAL/SURGICAL SIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION) 197
TABLE 190 MIDDLE EAST & AFRICA: MEDICAL SIMULATION TRAINING SERVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 198
TABLE 191 MIDDLE EAST & AFRICA: MEDICAL SIMULATION MARKET, BY END USER, 2020–2027 (USD MILLION) 198

10 COMPETITIVE LANDSCAPE 199
10.1 OVERVIEW 199
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 199
TABLE 192 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2019 AND SEPTEMBER 2022 200
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 201
10.4 MARKET SHARE ANALYSIS 201
FIGURE 34 MEDICAL SIMULATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021 202
10.4.1 SURGICAL SIMULATORS MARKET RANKING ANALYSIS 203
FIGURE 35 SURGICAL SIMULATORS MARKET RANKING ANALYSIS, BY KEY PLAYER, 2021 203
10.5 COMPETITIVE LEADERSHIP MAPPING 203
10.5.1 STARS 203
10.5.2 EMERGING LEADERS 204
10.5.3 PERVASIVE PLAYERS 204
10.5.4 PARTICIPANTS 204
FIGURE 36 MEDICAL SIMULATION MARKET: COMPETITIVE LEADERSHIP MAPPING FOR KEY PLAYERS (2021) 205
10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS 206
10.6.1 PROGRESSIVE COMPANIES 206
10.6.2 DYNAMIC COMPANIES 206
10.6.3 STARTING BLOCKS 206
10.6.4 RESPONSIVE COMPANIES 206
FIGURE 37 MEDICAL SIMULATION MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2021) 207
10.7 COMPETITIVE SCENARIO 208
TABLE 194 KEY DEALS, JANUARY 2019 TO SEPTEMBER 2022 208
TABLE 195 OTHER KEY DEVELOPMENTS, JANUARY 2019 TO SEPTEMBER 2022 209
10.8 COMPETITIVE BENCHMARKING 210
TABLE 196 PRODUCT & SERVICE FOOTPRINT OF COMPANIES (25 COMPANIES) 211
TABLE 197 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 212
11 COMPANY PROFILES 213
11.1 KEY PLAYERS 213
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 CAE INC. 213
TABLE 198 CAE INC.: BUSINESS OVERVIEW 213
FIGURE 38 CAE INC.: COMPANY SNAPSHOT (2021) 214
11.1.2 LAERDAL MEDICAL 218
TABLE 199 LAERDAL MEDICAL: BUSINESS OVERVIEW 218
11.1.3 GAUMARD SCIENTIFIC CO. 224
TABLE 200 GAUMARD SCIENTIFIC: BUSINESS OVERVIEW 224
11.1.4 KYOTO KAGAKU 235
TABLE 201 KYOTO KAGAKU: BUSINESS OVERVIEW 235
11.1.5 LIMBS & THINGS 242
TABLE 202 LIMBS & THINGS: BUSINESS OVERVIEW 242
11.1.6 MENTICE AB 247
TABLE 203 MENTICE AB: BUSINESS OVERVIEW 247
FIGURE 39 MENTICE AB: COMPANY SNAPSHOT (2021) 247
11.1.7 SIMULAB CORPORATION 251
TABLE 204 SIMULAB CORPORATION: BUSINESS OVERVIEW 251
11.1.8 SIMULAIDS 260
TABLE 205 SIMULAIDS: BUSINESS OVERVIEW 260
11.1.9 INTELLIGENT ULTRASOUND GROUP PLC 269
TABLE 206 INTELLIGENT ULTRASOUND GROUP PLC.: BUSINESS OVERVIEW 269
FIGURE 40 INTELLIGENT ULTRASOUND GROUP PLC: COMPANY SNAPSHOT (2021) 270
11.1.10 OPERATIVE EXPERIENCE INC. 273
TABLE 207 OPERATIVE EXPERIENCE INC.: BUSINESS OVERVIEW 273
11.1.11 SURGICAL SCIENCE SWEDEN AB 275
TABLE 208 SURGICAL SCIENCE SWEDEN AB: BUSINESS OVERVIEW 275
FIGURE 41 SURGICAL SCIENCE SWEDEN AB: COMPANY SNAPSHOT (2021) 275
11.1.12 CARDIONICS INC. (SUBSIDIARY OF 3B SCIENTIFIC) 278
TABLE 209 CARDIONICS INC.: BUSINESS OVERVIEW 278
11.1.13 VIRTAMED AG 280
TABLE 210 VIRTAMED AG: BUSINESS OVERVIEW 280
11.1.14 SYNBONE AG 282
TABLE 211 SYNBONE AG: BUSINESS OVERVIEW 282
11.1.15 INGMAR MEDICAL 284
TABLE 212 INGMAR MEDICAL: BUSINESS OVERVIEW 284
11.1.16 MEDICAL-X 286
TABLE 213 MEDICAL-X: BUSINESS OVERVIEW 286
11.1.17 KAVO DENTAL GMBH 289
TABLE 214 KAVO DENTAL GMBH: BUSINESS OVERVIEW 289
11.1.18 ALTAY SCIENTIFIC 290
TABLE 215 ALTAY SCIENTIFIC: BUSINESS OVERVIEW 290
11.1.19 TRUCORP LTD. 295
TABLE 216 TRUCORP LTD.: BUSINESS OVERVIEW 295
11.1.20 SIMENDO B.V. 297
TABLE 217 SIMENDO B.V.: BUSINESS OVERVIEW 297
11.2 OTHER PLAYERS 298
11.2.1 HAAG-STREIT SIMULATION 298
11.2.2 SYMGERY 298
11.2.3 HRV SIMULATION 299
11.2.4 SYNAPTIVE MEDICAL 299
11.2.5 INOVUS MEDICAL 300
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 301
12.1 DISCUSSION GUIDE 301
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 307
12.3 AVAILABLE CUSTOMIZATIONS 309
12.4 RELATED REPORTS 309
12.5 AUTHOR DETAILS 310


    お問合せフォーム

    • レポートのタイトルは自動で入ります。
    • *のある項目は必須項目です。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com